Gilaberte, Y, Yélamos, O, Cañueto, J, Serra-Guillén, C, Conti, A, Pajuelo, F, Lecchi, A, Cappello, V, Kostov, B, Padullés, L, Romanelli, M. Patient-and Clinician-reported Outcomes, Safety and Efficacy Profile of Tirbanibulin 1% for Actinic Keratosis Under Conditions Close to Routine Clinical Practice in Spain and Italy (TIRBASKIN Study). Actas Dermo-Sifiliograficas. 2026; 117(7)DOI:10.1016/j.ad.2026.104632. PMID:41864466. IF:(Q/D).

Tulleuda, R, Arias-Santiago, S, Armesto, S, Carrascosa, JM, Feltes, R, Pérez-Suárez, B, de la Cueva, P, López-Ferrer, A. Management of the Impact of Psoriasis on Sexuality: Consensus Recommendations From the Psoriasis Working Group of the Spanish Academy of Dermatology and Venereology. Actas Dermo-Sifiliograficas. 2026; 117(7)DOI:10.1016/j.ad.2026.104633. PMID:41864465. IF:(Q/D).

Armario-Hita, JC, Galán-Gutierrez, M, Pereyra-Rodríguez, JJ, Suarez-Pérez, J, Rodríguez-Serna, M, de Frutos, JO, Carrascosa, JM, Serra-Baldrich, E, Figueras-Nar, I, Zaragoza-Ninet, V, Ruiz-Villaverde, R. Real-World Effectiveness and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: A Multicenter Study From Spain. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2026; 65(6)DOI:10.1111/ijd.70185. PMID:41310412. IF:3.200(Q1/3D).

Figueras-Nart, I, Castillo, RO, Baldrich, ES. Experience in the management of real-world patients with chronic prurigo nodularis in a dermatology setting: results from the ECOSPIN Spanish survey-based study. Frontiers in Medicine. 2026; 13DOI:10.3389/fmed.2026.1769149. PMID:42058418. IF:3.000(Q1/2D).